Nutritional support for patients with COVID-19 coronavirus infection

Cover Page

Cite item

Full Text

Abstract

Prophylaxis, diagnostics and correction of nutritional status disturbances is considered as one of the main treatment methods of patients with COVID-19 infection-directed to resolve systemic inflammatory response and correction of metabolic response to a viral infection. Systemic Inflammatory Reaction (SIR) manisfestation as a result of viral infection leads to pronounced metabolic processes disturbances. The main metabolic manifestations of SIR is reflected as hypermetabolic-hypercatabolic syndrome with complex disturbances of protein, lipids and carbohydrates metabolism, increased consumption of carbohydrate-lipid reserves and breakdown of tissue proteins. Thus, adequate correction of metabolic disorders and a wholesome nutritional support, taking into account the clinical picture, severity of the disease, ongoing respiratory and intensive care therapy is an integral component in treating patients with COVID-19 infection which determines the efficiency of its treatment and reduction in mortality. Given the relevance of the problem, the authors decided that it was important to increase the COVID-19 treatment efficacy by producing guidelines based on the most fundamental provisions of the modern approach to nutritional support in critical patients with community acquired pneumonia, acute respiratory failure, ARDS, sepsis, multiple organ failure.

About the authors

A. V. Grechko

Federal State Budgetary Scientifi c Institution “Federal Research and Clinical Center for Resuscitation and Rehabilitology”

Email: krkerk@gmail.com
SPIN-code: 4865-8723

д.м.н., профессор, чл.-корр. РАН, директор

Russian Federation, Moscow

E. A. Evdokimov

Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian Federation

Email: krkerk@gmail.com
SPIN-code: 1296-7365

д.м.н., профессор, заведующий кафедрой анестезиологии и неотложной медицины

Russian Federation, Moscow

O. N. Kotenko

Moscow City clinical hospital № 52

Email: krkerk@gmail.com

к.м.н., заместитель главного врача по нефрологии

Russian Federation, Moscow

K. Yu. Krylov

Federal State Autonomous Educational Institution of Higher Education “Pirogov Russian National Research Medical University” of the Ministry of Education of Russia; Main Military Clinical Hospital named aft er N.N. Burdenko

Author for correspondence.
Email: krkerk@gmail.com
ORCID iD: 0000-0002-1807-7546

 

 

Russian Federation, Москва

E. V. Kryukov

Main Military Clinical Hospital named aft er N.N. Burdenko

Email: krkerk@gmail.com
SPIN-code: 3900-3441

д.м.н., профессор, чл.-корр. РАН, начальник госпиталя

Russian Federation, Moscow

V. M. Luft

Saint-Petersburg institute of emergency care n.a. I.I. Dzhanelidze

Email: krkerk@gmail.com
SPIN-code: 2003-5693

д.м.н., профессор, руководитель лаборатории клинического питания

Russian Federation, Saint-Petersburg

D. B. Nikityuk

Federal Research Center of Nutrition, Biotechnology and Food Safety

Email: krkerk@gmail.com
SPIN-code: 1236-8210

д.м.н., профессор, чл.-корр. РАН, директор

Russian Federation, Moscow

S. S. Petrikov

N.V. Sklifosovsky Research Institute of Emergency Care, Moscow Healthcare Department

Email: krkerk@gmail.com

д.м.н., профессор, чл.-корр. РАН, директор

Russian Federation, Moscow

M. V. Petrova

Federal State Budgetary Scientifi c Institution “Federal Research and Clinical Center for Resuscitation and Rehabilitology”

Email: mpetrova@fnkcrr.ru
ORCID iD: 0000-0003-4272-0957
SPIN-code: 9132-4190

д.м.н., заместитель директора по научно-клинической деятельности

Russian Federation, Moscow

A. V. Pogozheva

Federal Research Center of Nutrition, Biotechnology and Food Safety

Email: mpetrova@fnkcrr.ru
SPIN-code: 7428-8920

д.м.н., профессор, ведущий научный сотрудник

Russian Federation, Moscow

T. S. Popova

N.V. Sklifosovsky Research Institute of Emergency Care, Moscow Healthcare Department

Email: mpetrova@fnkcrr.ru
SPIN-code: 3122-8663

д.б.н., профессор, заведующая лабораторией экспериментальной патологии

Russian Federation, Moscow

D. N. Protsenko

Moscow City clinical hospital № 40

Email: mpetrova@fnkcrr.ru
SPIN-code: 1019-8216

к.м.н. главный врач

Russian Federation, Moscow

A. A. Ryk

N.V. Sklifosovsky Research Institute of Emergency Care, Moscow Healthcare Department

Email: mpetrova@fnkcrr.ru

к.м.н., руководитель группы искусственного питания

Russian Federation, Moscow

S. V. Sviridov

Federal State Autonomous Educational Institution of Higher Education “Pirogov Russian National Research Medical University” of the Ministry of Education of Russia

Email: mpetrova@fnkcrr.ru
SPIN-code: 4974-9195

д.м.н., заведующий кафедрой анестезиологии, реаниматологии и интенсивной терапии лечебного факультета

Russian Federation, Moscow

A. V. Starodubova

Federal Research Center of Nutrition, Biotechnology and Food Safety

Email: mpetrova@fnkcrr.ru
SPIN-code: 3538-6196

д.м.н., профессор, заместитель директора по научной и лечебной работе

Russian Federation, Moscow

V. V. Stets

Main Military Clinical Hospital named aft er N.N. Burdenko

Email: mpetrova@fnkcrr.ru

руководитель Центра анестезиологии-реанимации, реанимации и интенсивной терапии

Russian Federation, Moscow

I. Yu. Tarmayeva

Irkutsk State Medical University

Email: mpetrova@fnkcrr.ru
SPIN-code: 7490-4155

д.м.н., профессор кафедры профильных гигиенических дисциплин медико-профилактического факультета

Russian Federation, Irkutsk

V. A. Tutelyan

Federal Research Center of Nutrition, Biotechnology and Food Safety

Email: mpetrova@fnkcrr.ru

д.м.н., академик РАН, профессор, научный руководитель

Russian Federation, Moscow

Kh. Kh. Sharafetdinov

Federal Research Center of Nutrition, Biotechnology and Food Safety

Email: mpetrova@fnkcrr.ru
ORCID iD: 0000-0001-6061-0095

д.м.н., заведующий отделением болезней обмена веществ

Russian Federation, Moscow

A. E. Shestopalov

Federal State Budgetary Scientifi c Institution “Federal Research and Clinical Center for Resuscitation and Rehabilitology”; Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian Federation

Email: mpetrova@fnkcrr.ru
SPIN-code: 7531-6925

д.м.н., профессор, главный научный сотрудник лаборатории клинического питания и метаболизма НИИ реабилитологии; профессор кафедры анестезиологии и неотложной медицины

Russian Federation, Moscow

A. V. Yakovleva

Federal State Budgetary Scientifi c Institution “Federal Research and Clinical Center for Resuscitation and Rehabilitology”

Email: mpetrova@fnkcrr.ru

младший научный сотрудник лаборатории клинического питания и метаболизма НИИ реабилитологии

Russian Federation, Moscow

References

  1. Министерство здравоохранения Российской Федерации. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции. Версия 4 (27.03.2020) [Internet]. [Ministry of health of the Russian Federation. Vremennyye metodicheskiye rekomendatsii. Profilaktika, diagnostika i lecheniye novoy koronarovirusnoy infektsii. Version 4 (27.03.2020). (In Russ).] Доступно по: https://static-3.rosminzdrav.ru/system/attachments/ attaches/000/049/877/original/COVID19_recomend_v4.pdf. Ссылка активна на 12.06.2020.
  2. World Health Organization. Рекомендации по тактике ведения тяжелой острой респираторной инфекции (ТОРИ) при подозрении на COVID-19: временное руководство (перевод на русский язык от 21 марта 2020) [Internet]. [World Health Organization. Rekomendatsii po taktike vedeniya tyazheloy ostroy respiratornoy infektsii (TORI) pri podozrenii na COVID-19: vremennoye rukovodstvo (perevod na russkiy yazyk ot 21.03.2020). (In Russ).] Доступно по: https://ott.ru/files/news/ common/2020/20200317_karantin/voz_covid_19_ vremennoe_rukovodstvo_13032020.pdf. Ссылка активна на 12.06.2020.
  3. Conti P, Ronconi G, Caraffa A, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34(2):1−11. doi: 10.23812/CONTI-E.
  4. Gorbalenya AE. Severe acute respiratory syndrome- related coronavirus — the species and its viruses, a statement of the Coronavirus Study Group. 2020. https://doi.org/ 10.1101/2020.02.07.937862.
  5. Коровин А.Е., Новицкий А.А., Макаров Д.А. Острый респираторный дистресс-синдром. Современное состояние проблемы // Клиническая патофизиология. — 2018. — Т. 24. — № 2. — С. 32−41. [Korovin AE, Novitskiy AA, Makarov DA. Acute respiratory distress syndrome. Current state of the problem. Clinical pathophysiology. 2018;24(2): 32−41. (In Russ).]
  6. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus Disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):1−11. doi: 10.1001/jamainternmed.2020.0994.
  7. Никифоров В.В., Суранова Т.Г., Миронов А.Ю., Забозлаев Ф.Г. Новая коронавирусная инфекция (COVID-19): этиология, эпидемиология, клиника, диагностика, лечение и профилактика. — М., 2020. — 48 с. [Nikiforov VV, Suranova TG, Mironov AYu, Zabozlayev FG. Novaya koronavirusnaya infektsiya (COVID-19): etiologiya, epidemiologiya, klinika, diagnostika, lecheniye i profilaktika. Moscow; 2020. 48 р. (In Russ).]
  8. Pan L, Mu M, Yang P, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China:descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115(5):766–773. doi: 10.14309/ajg.0000000000000620.
  9. Шестопалов А.Е. Современные подходы к периоперационной нутритивной поддержке в онкохирургии // Вестник интенсивной терапии. — 2016. — № 2. — С. 5−14. [Shestopalov AE. Sovremennyye podkhody k perioperatsionnoy nutritivnoy podderzhke v onkokhirurgii. Vestnik intensivnoy terapii. 2016;(2):5−14. (In Russ).]
  10. Greenwood J.; RD, Clinical Dietitian Specialist, VCHA-VA. Reviewed by members of the ICU QI/QA Committee 11/7/08 [cited 2009 Dec 7]. Available from: https://www.criticalcarenutrition.com/docs/tools/Propofol.pdf.
  11. Шестопалов А.Е., Попова Т.С. Патофизиология синдрома кишечной недостаточности. В кн.: Интенсивная терапия: национальное руководство / Под ред. Б.Р. Гельфанд, И.Б. Заболотских. — М.: ГЭОТАР- Медиа, 2019. — С. 735−743. [Shestopalov AE, Popova TS. Patofiziologiya sindroma kishechnoy nedostatochnosti. In: Intensivnaya terapiya: natsional’noye rukovodstvo. Ed by B.R. Gel’fand, I.B. Zabolotskikh. Moscow: GEOTAR- Media; 2019. Р. 735−743. (In Russ).]
  12. Cheng Y, Luo R, Wang K, et al. Kidney impairment is associated with in-hospital death of COVID-19 рatients. Kidney Int. 2020;97(5):829−838. doi: 10.1016/ j.kint.2020.03.005.
  13. Ronco C, Reis T, Husain-Syed F. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med. 2020;8(7):738−742. doi: 10.1016/S2213-2600(20)30229-0.
  14. Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019;394(10212):1949–1964. doi: 10.1016/S0140-6736(19)32563-2.
  15. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234):1417–1418. doi: 10.1016/S0140-6736(20) 30937-5.
  16. Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219−227. doi: 10.1016/ j.kint.2020.04.003.
  17. Larsen CP, Bourne TD, Wilson JD, et al. Collapsing glomerulopathy in a patient with coronavirus disease 2019 (COVID-19). Kidney Int Rep. 2020;5(6):935−939. doi: 10.1016/j.ekir.2020.04.002.
  18. Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. 2020;16(6):308−310. doi: 10.1038/s41581-020-0284-7.
  19. Alhazzani W, Moller MH, Arabi YM, et al. Intensive care medicine. GUIDELINES. Surviving sepsis campaign: guidelines on the management of critically ill. adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854−887. doi: 10.1007/s00134-020-06022-5.
  20. Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Int Care Med. 2017; 43(3):304−377. doi: 10.1007/s00134-017-4683-6.
  21. Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38(1):48−79. doi: 10.1016/j.clnu.2018.08.037.
  22. Ramanathan K, Antognini D, Combes A, et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med. 2020;8(5):518−526. doi: 10.1016/S2213-2600(20)30121-1.
  23. Shekar K, Badulak J, Peek G, et al. Extracorporeal life support organization COVID-19 interim guidelines. ASAIO J. 2020;10.1097/MAT.0000000000001193. doi: 10.1097/MAT. 0000000000001193.
  24. Martindale R, Patel JJ, Taylor B, et al. Nutrition therapy in the patient with COVID-19 disease requiring ICU care. [cited 2020 April 1]. Available from: https://www.sccm.org/ COVID19RapidResources/Resources/Nutrition-Therapy-in-the-Patient-with-COVID-19-Dis.
  25. Белкин А.А. Синдром последствий интенсивной терапии (ПИТ-синдром) // Вестник интенсивной терапии им. А.И. Салтанова. — 2018. — № 2. — С. 12−23. [Belkin AA. Syndrome effects of intensive therapy — post intensive care syndrome (PICS). Alexander Saltanov intensive care herald. 2018;(2):12−23. (In Russ).] doi: 10.21320/1818-474X-2018-2-12-23.
  26. McClave SA, DiBaise JK, Mullin GE, Martindale RG. ACG clinical guideline: nutrition therapy in the adult hospitalized patient. Am J Gastroenterol. 2016;111(3):315−334. doi: 10.1038/ajg.2016.28.
  27. BAPEN. Nutritional Assessment [cited 2016 May 18]. P. 1−5. Available from: Bapen.org.uk.
  28. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically III Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) JPEN J Parenter Enteral Nutr. 2016;40(2):159–211. doi: 10.1177/0148607115621863.
  29. Malandraki GA, Markaki V, Georgopoulos VC, et al. Postextubation dysphagia in critical patients: a first report from the largest step-down intensive care unit in Greece. Am J Speech Lang Pathol. 2016;25(2):150−156. doi: 10.1044/2015_AJSLP-14-0069.
  30. Barazzoni R, Bischoff SC, Breda J, et al.; Endorsed by the ESPEN Council. ESPEN expert statements and practical guidance for nutritional management of individuals with Sars-CoV-2 infection. Clin Nutr. 2020;39(6):1631−1638. doi: 10.1016/j.clnu.2020.03.022.
  31. Griffiths RD. Glutamine in the critically ill patient: can it affect mortality? Clin Nutr Suppl. 2004;1(1):25−32. doi: 10.1016/j.clnu.2004.07.007.
  32. Vigeland CL, Beggs HS, Collins SL, et al. Inhibition of glutamine metabolism accelerates resolution of acute lung injury. Physiol Rep. 2019;7(5):e14019. doi: 10.14814/phy2.14019.
  33. Oliveira GP, de Abreu MG, Pelosi P, Rocco PR. Exogenous glutamine in respiratory diseases: myth or reality? Nutrients. 2016; 8(2):76. doi: 10.3390/nu8020076.
  34. Chiumello D. Editor. Acute respiratory distress syndrome. Springer International Publishing Switzerland; 2017. 341 р. doi: 10.1007/978-3-319-41852-0.
  35. Oliveira GP, Kitoko JZ, de Souza Lima-Gomes P, et al. Glutamine therapy reduces inflammation and extracellular trap release in experimental acute respiratory distress syndrome of pulmonary origin. Nutrients. 2019;11(4):831. doi: 10.3390/nu11040831.
  36. College of Intensive Care Medicine of Australia and New Zealand. The Australian and New Zealand Intensive Care Society (ANZICS) COVID-19 Guidelines Version 1 [cited 2020 Mar 17]. Available from: https://www.cicm.org.au/ News-Summary/ANZICS-COVID-19-Guidelines- Version-1.
  37. Стец В.В., Панова Н.Г., Шестопалов А.Е., и др. Эффективность энтерального введения фармаконутриентов в коррекции метаболических нарушений и разрешении синдрома кишечной недостаточности у больных, перенесших расширенные гастропанкреатодуоденальные резекции // Эффективная фармакотерапия. — 2015. — № 12. — С. 30−35. [Stets VV, Panova NG, Shestopalov AY, et al. Efficacy of enteral route of administration for pharmaconutrients in correcting metabolic disorders and relieving syndrome of intestinal insufficiency in patients after extended gastropancreatoduodenal resection. Effective pharmacotherapy. 2015;(12):30−35. (In Russ).]
  38. Forbes A, Escher J, Hebuterne X, Klek S. ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017;36(2):321–347. doi: 10.1016/j.clnu.2016.12.027.
  39. EuroElso survey on ECMO use in adult COVID-19 patients in Europe [cited 27 July 2020]. Available from: www.euroelso.net/covid-19/covid-19-survey/.
  40. Munshi L, Walkey A, Goligher E, et al. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med. 2019;7(2):163−172. doi: 10.1016/S2213-2600(18)30452-1.
  41. Matthay MA, Aldrich JM, Gotts JE. Treatment for severe acute respiratory distress syndrome from COVID-19. Lancet Respir Med. 2020;8(5):433−435. doi: 10.1016/S2213-2600(20)30127-2.
  42. Sobotka L. ESPEN Book: Basics in Clinical Nutrition. Galen; 2019.
  43. Руднов В.А. Клинические перспективы использования омега-3 жирных кислот в интенсивной терапии критических состояний, осложненных синдромом системного воспаления // Инфекции в хирургии. — 2007. — Т. 5. — № 4. — С. 25−30. [Rudnov VА. Clinical prospects of use of omega-3-fatty acids in the intensive therapy of critical conditions, complicated with the systemic inflammation syndrome. Infections in surgery 2007;5(4):25−30. (In Russ).]
  44. Heller AR. Omega-3 fatty acids improve the diagnosis- related clinical outcome. Crit Care Med. 2006;34(4): 972−979. doi: 10.1097/01.CCM.0000206309.83570.45.
  45. Попова Т.С. Острая кишечная недостаточность как проявление постагрессивной реакции организма. Руководство по клиническому питанию / Под ред. В.М. Луфта. — СПб.: Арт-Экспресс, 2016. — С. 175−189. [Popova TS. Ostraya kishechnaya nedostatochnost’ kak proyavleniye postagressivnoy reaktsii organizma. Rukovodstvo po klinicheskomu pitaniyu. Ed by V.M. Luft. Saint Petersburg: Art-Ekspress; 2016. Р. 175−189. (In Russ).
  46. Кислякова Е.А. Трибутирин в коррекции послеоперационных нарушений электрической активности тонкой кишки: Автореф. дис. … канд. биол. наук. — М., 2016. — 25 с. [Kislyakova EA. Tributirin v korrektsii posleoperatsionnykh narusheniy elektricheskoy aktivnosti tonkoy kishki. [dissertation abstract] Moscow; 2016. 25 р. (In Russ).]
  47. Тропская Н.С., Кислякова Е.А., Попова Т.С. Механизмы моторных нарушений тонкой кишки при эндотоксемии и патофизиологическое обоснование для использования трибутирина как противовоспалительного и прокинетического фармаконутриента // Анестезиология и реаниматология. — 2016. — Т. 61. — № 1. — С. 43−47. [Tropskaya NS, Kislyakova EA, Popova TS. Mechanisms of small intestine motor disorders during endotoxemia and pathophysiological rationale for the use of tributyrine as antiinflammatory and prokinetic pharmaconutrient. Anаеsthesiology and reanimatology. 2016;61(1): 43−47. (In Russ).] doi: 10.18821/0201-7563-2016-61-1-43-47.
  48. Hardin CC, Hibbert K. ECMO for severe acute respiratory distress syndrome. N Engl J Med. 2018;379(11):1092−1093. doi: 10.1056/NEJMc1808731.
  49. Ridley EJ, Davies AR, Robins EJ, et al. Nutrition therapy in adult patients receiving extracorporeal membrane oxygenation: a prospective, multicentre, observational study. Crit Care Resusc. 2015;17(3):183−189.
  50. Bear DE, Smith E, Barrett NA. Nutrition support in adult patients receiving extracorporeal membrane oxygenation. Nutr Clin Pract. 2018;33(6):738−746. doi: 10.1002/ncp.10211.
  51. Ohbe H, Jo T, Yamana H, et al. Early enteral nutrition for cardiogenic or obstructive shock requiring venoarterial extracorporeal membrane oxygenation: a nationwide inpatient database study. Int Care Med. 2018;44(8):1258−1265. doi: 10.1007/s00134-018-5319-1.
  52. Critical Care Specialist Group (CCSG) of the BDA Guidance on management of nutrition and dietetic services during the COVID-19 pandemic. Version 1.2-24/03/2020. Available from: https://www.bda.uk.com/uploads/assets/f5215258-7a34-4426-83620ba89f87c638/63decf82-db85-41d7-b5a6cbabe757a4a2/CCSG-Guidance-for-COVID-19-Formatted.pdf.

Copyright (c) 2020 Grechko A.V., Evdokimov E.A., Kotenko O.N., Krylov K.Y., Kryukov E.V., Luft V.M., Nikityuk D.B., Petrikov S.S., Petrova M.V., Pogozheva A.V., Popova T.S., Protsenko D.N., Ryk A.A., Sviridov S.V., Starodubova A.V., Stets V.V., Tarmayeva I.Y., Tutelyan V.A., Sharafetdinov K.K., Shestopalov A.E., Yakovleva A.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies